Last10K.com

Mallinckrodt Plc (MNKTQ) SEC Filing 8-K Material Event for the period ending Thursday, January 25, 2024

Mallinckrodt Plc

HISTORY TOOLS
CIK: 1567892 Ticker: MNKTQ

View differences made from one to another to evaluate Mallinckrodt Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mallinckrodt Plc.

Continue

Assess how Mallinckrodt Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mallinckrodt Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Mallinckrodt Plc provided additional information to their SEC Filing as exhibits

Exhibit 10.1: Material Contract
Ticker: MNKTQ
CIK: 1567892
Form Type: 8-K Corporate News
Accession Number: 0001104659-24-006963
Submitted to the SEC: Fri Jan 26 2024 7:01:41 AM EST
Accepted by the SEC: Fri Jan 26 2024
Period: Thursday, January 25, 2024
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mnktq/0001104659-24-006963.htm